Death by transposition - the enemy within?

BioEssays

Volumn 35, Issue 12, 2013, Pages 1035-1043

  Sedivy, John M ^a   Kreiling, Jill A ^a   Neretti, Nicola ^a   Cecco, Marco De ^a   Criscione, Steven W ^a   Hofmann, Jeffrey W ^a   Zhao, Xiaoai ^a   Ito, Takahiro ^a   Peterson, Abigail L ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Aging; Anti retroviral therapy; Cellular senescence; Retrotransposition

Indexed keywords

BETA GALACTOSIDASE; REACTIVE OXYGEN METABOLITE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

AGING; ARTICLE; CELL AGING; CHROMATIN; CPG ISLAND; DNA METHYLATION; EPIGENETICS; EUCHROMATIN; HUMAN; LIFE EXTENSION; LONG TERMINAL REPEAT; NONHUMAN; PARASITE; PHENOTYPE; RETROPOSON; SHORT INTERSPERSED REPEAT; SPONTANEOUS MUTATION; TISSUE REGENERATION; TRANSPOSON;

MAMMALIA;

AGING; ANTI-RETROVIRAL THERAPY; CELLULAR SENESCENCE; RETROTRANSPOSITION;

AGING; ANIMALS; CELL AGING; HUMANS; RETROELEMENTS;

EID: 84887626704     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201300097     Document Type: Article

References (98)

1. Niccoli T, Partridge L. 2012. Ageing as a risk factor for disease. Curr Biol 22: R741-52.
2. Donmez G, Guarente L. 2010. Aging and disease: connections to sirtuins. Aging Cell 9: 285-90.
3. Miller RA. 2012. Genes against aging. J Gerontol A Biol Sci Med Sci 67: 495-502.
4. Partridge L, Alic N, Bjedov I, Piper MD. 2011. Ageing in Drosophila: the role of the insulin/Igf and TOR signalling network. Exp Gerontol 46: 376-81.
5. Harrison DE, Strong R, Sharp ZD, Nelson JF, et al. 2009. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460: 392-5.
6. Mercken EM, Carboneau BA, Krzysik-Walker SM, de Cabo R. 2012. Of mice and men: the benefits of caloric restriction, exercise, and mimetics. Ageing Res Rev 11: 390-8.
7. Colman RJ, Anderson RM, Johnson SC, Kastman EK, et al. 2009. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 325: 201-4.
8. Mattison JA, Roth GS, Beasley TM, Tilmont EM, et al. 2012. Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature 489: 318-21.
9. Pearson KJ, Baur JA, Lewis KN, Peshkin L, et al. 2008. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 8: 157-68.
10. Oberdoerffer P, Sinclair DA. 2007. The role of nuclear architecture in genomic instability and ageing. Nat Rev Mol Cell Biol 8: 692-702.
11. Taylor RC, Dillin A. 2011. Aging as an event of proteostasis collapse. Cold Spring Harb Perspect Biol 3: pii: a004440.
12. Sharpless NE, DePinho RA. 2007. How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol 8: 703-13.
13. Sedivy JM, Munoz-Najar UM, Jeyapalan JC, Campisi J. 2007. Cellular senescence: A link between tumor suppression and organismal aging? In Guarente L, Partridge L, eds; The Molecular Biology of Aging. Cold Spring Harbor: Cold Spring Harbor Laboratory Press.
14. Larsson LG. 2011. Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence. Semin Cancer Biol 21: 367-76.
15. Peeper DS. 2011. Oncogene-induced senescence and melanoma: where do we stand? Pigment Cell Melanoma Res 24: 1107-11.
16. Adams PD. 2009. Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence. Mol Cell 36: 2-14.
17. Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O. 2009. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 4: 1798-806.
18. Herbig U, Jobling WA, Chen BP, Chen DJ, et al. 2004. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell 14: 501-13.
19. Herbig U, Ferreira M, Condel L, Carey D, et al. 2006. Cellular senescence in aging primates. Science 311: 1257.
20. Waaijer ME, Parish WE, Strongitharm BH, van Heemst D, et al. 2012. The number of p16INK4a positive cells in human skin reflects biological age. Aging Cell 11: 722-5.
21. Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, et al. 2011. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479: 232-6.
22. Tchkonia T, Zhu Y, van Deursen J, Campisi J, et al. 2013. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest 123: 966-72.
23. Drenos F, Kirkwood TB. 2005. Modelling the disposable soma theory of ageing. Mech Ageing Dev 126: 99-103.
24. Kirkwood TB, Holliday R. 1979. The evolution of ageing and longevity. Proc R Soc Lond B Biol Sci 205: 531-46.
25. O'Sullivan RJ, Karlseder J. 2012. The great unravelling: chromatin as a modulator of the aging process. Trends Biochem Sci 37: 466-76.
26. Sedivy JM, Banumathy G, Adams PD. 2008. Aging by epigenetics-a consequence of chromatin damage? Exp Cell Res 314: 1909-17.
27. Ivanov A, Pawlikowski J, Manoharan I, van Tuyn J, et al. 2013. Lysosome-mediated processing of chromatin in senescence. J Cell Biol 202: 129-43.
28. O'Sullivan RJ, Kubicek S, Schreiber SL, Karlseder J. 2010. Reduced histone biosynthesis and chromatin changes arising from a damage signal at telomeres. Nat Struct Mol Biol 17: 1218-25.
29. Feser J, Truong D, Das C, Carson JJ, et al. 2010. Elevated histone expression promotes life span extension. Mol Cell 39: 724-35.
30. Greer EL, Maures TJ, Hauswirth AG, Green EM, et al. 2010. Members of the H3K4 trimethylation complex regulate lifespan in a germline-dependent manner in C. elegans. Nature 466: 383-7.
31. Chandra T, Narita M. 2013. High-order chromatin structure and the epigenome in SAHFs. Nucleus 4: 23-8.
32. Singhal RP, Mays-Hoopes LL, Eichhorn GL. 1987. DNA methylation in aging of mice. Mech Ageing Dev 41: 199-210.
33. Wilson VL, Smith RA, Ma S, Cutler RG. 1987. Genomic 5-methyldeoxycytidine decreases with age. J Biol Chem 262: 9948-51.
34. Deaton AM, Bird A. 2011. CpG islands and the regulation of transcription. Genes Dev 25: 1010-22.
35. Estecio MR, Issa JP. 2011. Dissecting DNA hypermethylation in cancer. FEBS Lett 585: 2078-86.
36. De Cecco M, Criscione SW, Peckham EJ, Hillenmeyer S, et al. 2013. Genomes of replicatively senescent cells undergo global epigenetic changes leading to gene silencing and activation of transposable elements. Aging Cell 12: 247-56.
37. Huang CR, Burns KH, Boeke JD. 2012. Active transposition in genomes. Annu Rev Genet 46: 651-75.
38. de Koning AP, Gu W, Castoe TA, Batzer MA, et al. 2011. Repetitive elements may comprise over two-thirds of the human genome. PLoS Genet 7: e1002384.
39. Levin HL, Moran JV. 2011. Dynamic interactions between transposable elements and their hosts. Nat Rev Genet 12: 615-27.
40. Burns KH, Boeke JD. 2012. Human transposon tectonics. Cell 149: 740-52.
41. Beck CR, Collier P, Macfarlane C, Malig M, et al. 2010. LINE-1 retrotransposition activity in human genomes. Cell 141: 1159-70.
42. Lee E, Iskow R, Yang L, Gokcumen O, et al. 2012. Landscape of somatic retrotransposition in human cancers. Science 337: 967-71.
43. Dewannieux M, Esnault C, Heidmann T. 2003. LINE-mediated retrotransposition of marked Alu sequences. Nat Genet 35: 41-8.
44. Hancks DC, Kazazian HH Jr. 2012. Active human retrotransposons: variation and disease. Curr Opin Genet Dev 22: 191-203.
45. Ewing AD, Kazazian HH Jr. 2010. High-throughput sequencing reveals extensive variation in human-specific L1 content in individual human genomes. Genome Res 20: 1262-70.
46. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, et al. 2002. Initial sequencing and comparative analysis of the mouse genome. Nature 420: 520-62.
47. Shukla R, Upton KR, Munoz-Lopez M, Gerhardt DJ, et al. 2013. Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell 153: 101-11.
48. Solyom S, Ewing AD, Rahrmann EP, Doucet T, et al. 2012. Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res 22: 2328-38.
49. Rodic N, Burns KH. 2013. Long interspersed element-1 (LINE-1): passenger or driver in human neoplasms? PLoS Genet 9: e1003402.
50. Baillie JK, Barnett MW, Upton KR, Gerhardt DJ, et al. 2011. Somatic retrotransposition alters the genetic landscape of the human brain. Nature 479: 534-7.
51. Coufal NG, Garcia-Perez JL, Peng GE, Yeo GW, et al. 2009. L1 retrotransposition in human neural progenitor cells. Nature 460: 1127-31.
52. Thomas CA, Paquola AC, Muotri AR. 2012. LINE-1 retrotransposition in the nervous system. Annu Rev Cell Dev Biol 28: 555-73.
53. Evrony GD, Cai X, Lee E, Hills LB, et al. 2012. Single-neuron sequencing analysis of L1 retrotransposition and somatic mutation in the human brain. Cell 151: 483-96.
54. Kubo S, Seleme MC, Soifer HS, Perez JL, et al. 2006. L1 retrotransposition in nondividing and primary human somatic cells. Proc Natl Acad Sci USA 103: 8036-41.
55. Shi X, Seluanov A, Gorbunova V. 2007. Cell divisions are required for L1 retrotransposition. Mol Cell Biol 27: 1264-70.
56. Maxwell PH, Burhans WC, Curcio MJ. 2011. Retrotransposition is associated with genome instability during chronological aging. Proc Natl Acad Sci USA 108: 20376-81.
57. Li W, Prazak L, Chatterjee N, Gruninger S, et al. 2013. Activation of transposable elements during aging and neuronal decline in Drosophila. Nat Neurosci 16: 529-31.
58. Barbot W, Dupressoir A, Lazar V, Heidmann T. 2002. Epigenetic regulation of an IAP retrotransposon in the aging mouse: progressive demethylation and de-silencing of the element by its repetitive induction. Nucleic Acids Res 30: 2365-73.
59. Rodier F, Campisi J. 2011. Four faces of cellular senescence. J Cell Biol 192: 547-56.
60. Hagan CR, Sheffield RF, Rudin CM. 2003. Human Alu element retrotransposition induced by genotoxic stress. Nat Genet 35: 219-20.
61. Jolly C, Metz A, Govin J, Vigneron M, et al. 2004. Stress-induced transcription of satellite III repeats. J Cell Biol 164: 25-33.
62. Li T, Spearow J, Rubin CM, Schmid CW. 1999. Physiological stresses increase mouse short interspersed element (SINE) RNA expression in vivo. Gene 239: 367-72.
63. Valgardsdottir R, Chiodi I, Giordano M, Cobianchi F, et al. 2005. Structural and functional characterization of noncoding repetitive RNAs transcribed in stressed human cells. Mol Biol Cell 16: 2597-604.
64. Coufal NG, Garcia-Perez JL, Peng GE, Marchetto MC, et al. 2011. Ataxia telangiectasia mutated (ATM) modulates long interspersed element-1 (L1) retrotransposition in human neural stem cells. Proc Natl Acad Sci USA 108: 20382-7.
65. Jurk D, Wang C, Miwa S, Maddick M, et al. 2012. Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response. Aging Cell 11: 996-1004.
66. Kreiling JA, Tamamori-Adachi M, Sexton AN, Jeyapalan JC, et al. 2011. Age-associated increase in heterochromatic marks in murine and primate tissues. Aging Cell 10: 292-304.
67. Fumagalli M, Rossiello F, Clerici M, Barozzi S, et al. 2012. Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nat Cell Biol 14: 355-65.
68. Hewitt G, Jurk D, Marques FD, Correia-Melo C, et al. 2012. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat Commun 3: 708.
69. Rodier F, Munoz DP, Teachenor R, Chu V, et al. 2011. DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion. J Cell Sci 124: 68-81.
70. Muotri AR, Marchetto MC, Coufal NG, Oefner R, et al. 2010. L1 retrotransposition in neurons is modulated by MeCP2. Nature 468: 443-6.
71. Young JI, Sedivy JM, Smith JR. 2003. Telomerase expression in normal human fibroblasts stabilizes DNA 5-methylcytosine transferase I. J Biol Chem 278: 19904-8.
72. Czech B, Malone CD, Zhou R, Stark A, et al. 2008. An endogenous small interfering RNA pathway in Drosophila. Nature 453: 798-802.
73. Kawamura Y, Saito K, Kin T, Ono Y, et al. 2008. Drosophila endogenous small RNAs bind to Argonaute 2 in somatic cells. Nature 453: 793-7.
74. Khurana JS, Theurkauf W. 2010. piRNAs, transposon silencing, and Drosophila germline development. J Cell Biol 191: 905-13.
75. Malone CD, Brennecke J, Dus M, Stark A, et al. 2009. Specialized piRNA pathways act in germline and somatic tissues of the Drosophila ovary. Cell 137: 522-35.
76. Shoji M, Tanaka T, Hosokawa M, Reuter M, et al. 2009. The TDRD9-MIWI2 complex is essential for piRNA-mediated retrotransposon silencing in the mouse male germline. Dev Cell 17: 775-87.
77. Perrat PN, DasGupta S, Wang J, Theurkauf W, et al. 2013. Transposition-driven genomic heterogeneity in the Drosophila brain. Science 340: 91-5.
78. Ghildiyal M, Seitz H, Horwich MD, Li C, et al. 2008. Endogenous siRNAs derived from transposons and mRNAs in Drosophila somatic cells. Science 320: 1077-81.
79. Watanabe T, Totoki Y, Toyoda A, Kaneda M, et al. 2008. Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes. Nature 453: 539-43.
80. Yang N, Kazazian HH Jr. 2006. L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells. Nat Struct Mol Biol 13: 763-71.
81. Mori MA, Raghavan P, Thomou T, Boucher J, et al. 2012. Role of microRNA processing in adipose tissue in stress defense and longevity. Cell Metab 16: 336-47.
82. Shalgi R, Pilpel Y, Oren M. 2010. Repression of transposable-elements - a microRNA anti-cancer defense mechanism? Trends Genet 26: 253-9.
83. Bourc'his D, Bestor TH. 2004. Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L. Nature 431: 96-9.
84. Carmell MA, Girard A, van de Kant HJ, Bourc'his D, et al. 2007. MIWI2 is essential for spermatogenesis and repression of transposons in the mouse male germline. Dev Cell 12: 503-14.
85. Faulkner GJ, Kimura Y, Daub CO, Wani S, et al. 2009. The regulated retrotransposon transcriptome of mammalian cells. Nat Genet 41: 563-71.
86. Naito K, Zhang F, Tsukiyama T, Saito H, et al. 2009. Unexpected consequences of a sudden and massive transposon amplification on rice gene expression. Nature 461: 1130-4.
87. Akagi K, Li J, Symer DE. 2013. How do mammalian transposons induce genetic variation? A conceptual framework. BioEssays 35: 397-407.
88. St Laurent G III, Hammell N, McCaffrey TA. 2010. A LINE-1 component to human aging: do LINE elements exact a longevity cost for evolutionary advantage? Mech Ageing Dev 131: 299-305.
89. Belancio VP, Hedges DJ, Deininger P. 2008. Mammalian non-LTR retrotransposons: for better or worse, in sickness and in health. Genome Res 18: 343-58.
90. Belancio VP, Roy-Engel AM, Pochampally RR, Deininger P. 2010. Somatic expression of LINE-1 elements in human tissues. Nucleic Acids Res 38: 3909-22.
91. Gasior SL, Wakeman TP, Xu B, Deininger PL. 2006. The human LINE-1 retrotransposon creates DNA double-strand breaks. J Mol Biol 357: 1383-93.
92. Coppe JP, Patil CK, Rodier F, Sun Y, et al. 2008. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6: 2853-68.
93. Rodier F, Coppe JP, Patil CK, Hoeijmakers WA, et al. 2009. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol 11: 973-9.
94. Young GR, Stoye JP, Kassiotis G. 2013. Are human endogenous retroviruses pathogenic? An approach to testing the hypothesis. BioEssays 35: 794-803.
95. Oberdoerffer P, Michan S, McVay M, Mostoslavsky R, et al. 2008. SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell 135: 907-18.
96. Smith RL, de Boer R, Brul S, Budovskaya Y, et al. 2012. Premature and accelerated aging: HIV or HAART? Front Genet 3: 328.
97. Dai L, Huang Q, Boeke JD. 2011. Effect of reverse transcriptase inhibitors on LINE-1 and Ty1 reverse transcriptase activities and on LINE-1 retrotransposition. BMC Biochem 12: 18.
98. Jones RB, Garrison KE, Wong JC, Duan EH, et al. 2008. Nucleoside analogue reverse transcriptase inhibitors differentially inhibit human LINE-1 retrotransposition. PLoS One 3: e1547.